Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001649553-25-000130·BriaCell Therapeutics Corp.
Schedule 13G ownership disclosure
BriaCell Therapeutics Corp.
Common Shares, no par value · CUSIP: 107930208
Event date: 2025-07-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 1,000,000 · Class: 5.7%
- Heights Capital Management, Inc.
Shares: 1,000,000 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000130
- Form type
- SCHEDULE 13G
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- Jul 22, 2025
- Reporting period
- Jul 15, 2025
- Description
- Schedule 13G beneficial ownership